Immunoassay for cyclopropylindole based synthetic cannabinoids, metabolites and derivatives thereof
申请人:Randox Laboratories Ltd.
公开号:EP2781527A1
公开(公告)日:2014-09-24
The invention relates to the detection and quantification of cyclopropylindole based synthetic cannabinoids UR-144 and XLR-11 by providing antobodies based on novel immunogens.
These antobodies can be incorporated into methods and kits for the detection of UR-144, XLR-11 and metabolites or derivatives thereof.
本发明涉及通过提供基于新型免疫原的抗体来检测和定量环丙基吲哚类合成大麻素 UR-144 和 XLR-11。
这些抗体可纳入检测 UR-144、XLR-11 及其代谢物或衍生物的方法和试剂盒中。